Anti-inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosis.
Gurski F, Shirvanchi K, Rajendran V, Rajendran R, Megalofonou FF, Böttiger G, Stadelmann C, Bhushan S, Ergün S, Karnati S, Berghoff M.
Gurski F, et al. Among authors: rajendran v, rajendran r.
Br J Pharmacol. 2025 Jan;182(1):142-161. doi: 10.1111/bph.17341. Epub 2024 Oct 5.
Br J Pharmacol. 2025.
PMID: 39367768